推荐应用
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames.
推荐稀释比 WB:1/500-1/1000;IHC:1/100-1/200;FC:1/50-1/100;ELISA:1/10000

Immunohistochemistry analysis of paraffin-embedded human endometrial cancer tissues using Ataxin 1 antibody.
-25 ~ -15℃保存,收到货之后有效期1年,避免反复冻融。
【应用方向】单细胞表观测序中的抗体应用
307
2026-07-29
【选购指南】类器官研究之构建与起始细胞鉴定抗体推荐
686
2026-07-21
【选购指南】类器官研究之功能成熟度评估抗体推荐
519
2026-07-21
【应用方向】趋化因子信号传导通路——身体“信号导航”解析
526
2026-07-21
【选购指南】重度抑郁症(MDD)通路研究抗体推荐
501
2026-07-21
【选购指南】帕金森病(PD)代谢机制核心抗体研究指南
512
2026-07-21
【应用方向】抗体助力心脏免疫研究——解锁心衰防治新方向
458
2026-07-21
【应用方向】抗体助力心肌肥大与心衰研究:从基础探索到科研应用
485
2026-07-21
【应用方向】抗体助力癌症代谢通路研究——肿瘤代谢科普与研究工具指南
535
2026-07-21
【应用方向】心肌再生研究与抗体应用解决方案——助力心血管修复机制解析
13902
2026-03-18
【应用方向】抗体应用研究——心肌纤维化解析
20600
2026-04-14
【技术讲解】抗体赋能心肌梗死研究—精准靶向,助力科研突破
7516
2026-04-14
【应用方向】抗体应用研究—心肌发育的分子解析与前沿转化
15203
2026-04-14
【应用方向】抗体应用研究—细胞死亡
20465
2026-07-16
【应用方向】经典信号通路-JAK/STAT信号转导通路及抗体推荐
13385
2026-04-14





